UBS Group’s G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 GSQB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-600
Closed -$17 10255
2023
Q1
$17 Sell
600
-732
-55% -$34 ﹤0.01% 9437
2022
Q4
$40 Sell
1,332
-1,732
-57% -$114 ﹤0.01% 10498
2022
Q3
$0 Hold
3,064
﹤0.01% 11382
2022
Q2
$0 Buy
3,064
+2,864
+1,432% +$751 ﹤0.01% 11375
2022
Q1
$0 Buy
200
+100
+100% +$47 ﹤0.01% 11264
2021
Q4
$0 Buy
+100
New +$74 ﹤0.01% 11006

Other funds holding GSQB.WS

UBS Group's GSQB.WS Position: Q2 2023 in Review

UBS Group sold out of G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (GSQB.WS) in Q2 2023, closing a stake of 600 shares — an estimated $17 sold.

UBS Group first reported a position in GSQB.WS in Q4 2021 and held it in 6 quarters. The position peaked at $40 in Q4 2022. 3 funds tracked by Wall St. Rank hold GSQB.WS as of Q2 2023.

  • UBS Group reported no remaining G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 600 G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $17.
  • UBS Group first reported a position in G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 6 quarters.
  • UBS Group's G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $40 in Q4 2022.
  • 3 funds tracked by Wall St. Rank held G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.